| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Chief Executive Officer
1 company
Danahy Kevin Patrick is a Chief Commercial Officer at Pulse Biosciences, Inc.. Recent SEC Form 4 filings include 4 buys and 4 sells.
Estimated insider holdings value: $826K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | PLSE Pulse Biosciences, Inc. | Chief Commercial Officer | Sale+OE | 5,000 | $23.64 | $118,200.00 | -10.4% | - | - | |
| Oct 2, 2025 | PLSE Pulse Biosciences, Inc. | Chief Commercial Officer | Sale+OE | 4,600 | $18.53 | $85,238.00 | -9.6% | -27.7% | - | |
| Sep 19, 2025 | PLSE Pulse Biosciences, Inc. | Chief Commercial Officer | Sale+OE | 20,400 | $18.49 | $377,192.00 | -19.1% | -18.3% | - | |
| Nov 16, 2023 | PLSE Pulse Biosciences, Inc. | Chief Executive Officer | Buy | 5,393 | $6.52 | $35,155.64 | +5.3% | +40.7% | +166.7% | |
| Sep 30, 2022 | PLSE Pulse Biosciences, Inc. | Chief Executive Officer | Buy | 6,500 | $2.30 | $14,950.00 | New | +19.6% | +75.2% |